0
USD
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Therapeutic Nuclear Medicines Market Insights, Forecast to 2025
Published Date: May 2019
|
Report Code: QYRE-Auto-392
Home | Category |Health |Medical Devices & Equipment
Global Therapeutic Nuclear Medicines Market Insights Forecast to 2025

Global Therapeutic Nuclear Medicines Market Insights, Forecast to 2025

Code: QYRE-Auto-392
Report
May 2019
118 Pages
QYResearch
Region: Global, Europe, North America, Middle East, Asia Pacific,
Description
Table of Content
Tables & Figures
Radioactive material, called radiopharmaceuticals, can be used to treat certain conditions. This is called nuclear medicine therapy. Therapeutic nuclear medicines are a pharmaceutical formulation that consists of radioactive substances (radioisotopes). Therapeutic nuclear medicines are intending for the treatment of cancer, metastatic bone pain and other diseases. The radioactive material of therapeutic nuclear medicines is capable of killing the cancerous tissue, reducing the size of a tumor and reducing pain.
Radioactive material, called radiopharmaceuticals, can be used to treat certain conditions. This is called nuclear medicine therapy.
North Americas is the largest consumption place, with a revenue market share nearly 44.8% in 2018. Following North Americas, Europe is the second largest consumption place with the revenue market share of 29% in 2018.
The global Therapeutic Nuclear Medicines market is valued at 855 million US$ in 2018 and will reach 2723.6 million US$ by the end of 2025, growing at a CAGR of 18.0% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Therapeutic Nuclear Medicines market based on company, product type, end user and key regions.

This report studies the global market size of Therapeutic Nuclear Medicines in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Therapeutic Nuclear Medicines in these regions.
This research report categorizes the global Therapeutic Nuclear Medicines market by top players/brands, region, type and end user. This report also studies the global Therapeutic Nuclear Medicines market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:
    Bayer
    Novartis AG
    China Isotope & Radiation
    Dongcheng
    Q BioMed
    Curium Pharmaceuticals
    Jubilant DraxImage
    Lantheus
    Spectrum Pharmaceuticals
    Progenics Pharmaceuticals
    International Isotopes

Therapeutic Nuclear Medicines market size by Type
    Radium-223
    Lutetium-177
    Iodine-131
    Other
Therapeutic Nuclear Medicines market size by Applications
    Thyroid
    Bone Metastasis
    Lymphoma
    Other

Market size by Region
    North America
        United States
        Canada
        Mexico
    Asia-Pacific
        China
        Japan
        South Korea
        India
        Australia
        Indonesia
        Thailand
        Malaysia
        Philippines
        Vietnam
    Europe
        Germany
        France
        UK
        Italy
        Spain
        Russia
    Central & South America
        Brazil
        Rest of Central & South America
    Middle East & Africa
        Turkey
        GCC Countries
        Egypt
        South Africa

The study objectives of this report are:
    To study and analyze the global Therapeutic Nuclear Medicines market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
    To understand the structure of Therapeutic Nuclear Medicines market by identifying its various subsegments.
    To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
    Focuses on the key global Therapeutic Nuclear Medicines companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
    To project the value and sales volume of Therapeutic Nuclear Medicines submarkets, with respect to key regions.
    To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Therapeutic Nuclear Medicines are as follows:
    History Year: 2014-2018
    Base Year: 2018
    Estimated Year: 2019
    Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Therapeutic Nuclear Medicines market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents

1 Study Coverage
    1.1 Therapeutic Nuclear Medicines Product Introduction
    1.2 Market Segments
    1.3 Key Manufacturers Covered
    1.4 Market by Type
        1.4.1 Global Therapeutic Nuclear Medicines Market Size Growth Rate by Type
        1.4.2 Radium-223
        1.4.3 Lutetium-177
        1.4.4 Iodine-131
        1.4.5 Other
    1.5 Market by Application
        1.5.1 Global Therapeutic Nuclear Medicines Market Size Growth Rate by Application
        1.5.2 Thyroid
        1.5.3 Bone Metastasis
        1.5.4 Lymphoma
        1.5.5 Other
    1.6 Study Objectives
    1.7 Years Considered

2 Executive Summary
    2.1 Global Therapeutic Nuclear Medicines Market Size
        2.1.1 Global Therapeutic Nuclear Medicines Revenue 2014-2025
        2.1.2 Global Therapeutic Nuclear Medicines Sales 2014-2025
    2.2 Therapeutic Nuclear Medicines Growth Rate by Regions
        2.2.1 Global Therapeutic Nuclear Medicines Sales by Regions
        2.2.2 Global Therapeutic Nuclear Medicines Revenue by Regions

3 Breakdown Data by Manufacturers
    3.1 Therapeutic Nuclear Medicines Sales by Manufacturers
        3.1.1 Therapeutic Nuclear Medicines Sales by Manufacturers
        3.1.2 Therapeutic Nuclear Medicines Sales Market Share by Manufacturers
    3.2 Therapeutic Nuclear Medicines Revenue by Manufacturers
        3.2.1 Therapeutic Nuclear Medicines Revenue by Manufacturers (2014-2019)
        3.2.2 Therapeutic Nuclear Medicines Revenue Share by Manufacturers (2014-2019)
    3.3 Therapeutic Nuclear Medicines Price by Manufacturers
    3.4 Therapeutic Nuclear Medicines Manufacturing Base Distribution, Product Types
        3.4.1 Therapeutic Nuclear Medicines Manufacturers Manufacturing Base Distribution, Headquarters
        3.4.2 Manufacturers Therapeutic Nuclear Medicines Product Type
        3.4.3 Date of International Manufacturers Enter into Therapeutic Nuclear Medicines Market
    3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type
    4.1 Global Therapeutic Nuclear Medicines Sales by Type
    4.2 Global Therapeutic Nuclear Medicines Revenue by Type
    4.3 Therapeutic Nuclear Medicines Price by Type

5 Breakdown Data by Application
    5.1 Overview
    5.2 Global Therapeutic Nuclear Medicines Breakdown Data by Application

6 North America
    6.1 North America Therapeutic Nuclear Medicines by Country
        6.1.1 North America Therapeutic Nuclear Medicines Sales by Country
        6.1.2 North America Therapeutic Nuclear Medicines Revenue by Country
        6.1.3 United States
        6.1.4 Canada
        6.1.5 Mexico
    6.2 North America Therapeutic Nuclear Medicines by Type
    6.3 North America Therapeutic Nuclear Medicines by Application

7 Europe
    7.1 Europe Therapeutic Nuclear Medicines by Country
        7.1.1 Europe Therapeutic Nuclear Medicines Sales by Country
        7.1.2 Europe Therapeutic Nuclear Medicines Revenue by Country
        7.1.3 Germany
        7.1.4 France
        7.1.5 UK
        7.1.6 Italy
        7.1.7 Russia
    7.2 Europe Therapeutic Nuclear Medicines by Type
    7.3 Europe Therapeutic Nuclear Medicines by Application

8 Asia Pacific
    8.1 Asia Pacific Therapeutic Nuclear Medicines by Country
        8.1.1 Asia Pacific Therapeutic Nuclear Medicines Sales by Country
        8.1.2 Asia Pacific Therapeutic Nuclear Medicines Revenue by Country
        8.1.3 China
        8.1.4 Japan
        8.1.5 Korea
        8.1.6 India
        8.1.7 Australia
        8.1.8 Indonesia
        8.1.9 Malaysia
        8.1.10 Philippines
        8.1.11 Thailand
        8.1.12 Vietnam
        8.1.13 Singapore
    8.2 Asia Pacific Therapeutic Nuclear Medicines by Type
    8.3 Asia Pacific Therapeutic Nuclear Medicines by Application

9 Central & South America
    9.1 Central & South America Therapeutic Nuclear Medicines by Country
        9.1.1 Central & South America Therapeutic Nuclear Medicines Sales by Country
        9.1.2 Central & South America Therapeutic Nuclear Medicines Revenue by Country
        9.1.3 Brazil
        9.1.4 Argentina
    9.2 Central & South America Therapeutic Nuclear Medicines by Type
    9.3 Central & South America Therapeutic Nuclear Medicines by Application

10 Middle East and Africa
    10.1 Middle East and Africa Therapeutic Nuclear Medicines by Country
        10.1.1 Middle East and Africa Therapeutic Nuclear Medicines Sales by Country
        10.1.2 Middle East and Africa Therapeutic Nuclear Medicines Revenue by Country
        10.1.3 GCC Countries
        10.1.4 Turkey
        10.1.5 Egypt
        10.1.6 South Africa
    10.2 Middle East and Africa Therapeutic Nuclear Medicines by Type
    10.3 Middle East and Africa Therapeutic Nuclear Medicines by Application

11 Company Profiles
    11.1 Bayer
        11.1.1 Bayer Company Details
        11.1.2 Company Business Overview
        11.1.3 Bayer Therapeutic Nuclear Medicines Sales, Revenue and Gross Margin (2014-2019)
        11.1.4 Bayer Therapeutic Nuclear Medicines Products Offered
        11.1.5 Bayer Recent Development
    11.2 Novartis AG
        11.2.1 Novartis AG Company Details
        11.2.2 Company Business Overview
        11.2.3 Novartis AG Therapeutic Nuclear Medicines Sales, Revenue and Gross Margin (2014-2019)
        11.2.4 Novartis AG Therapeutic Nuclear Medicines Products Offered
        11.2.5 Novartis AG Recent Development
    11.3 China Isotope & Radiation
        11.3.1 China Isotope & Radiation Company Details
        11.3.2 Company Business Overview
        11.3.3 China Isotope & Radiation Therapeutic Nuclear Medicines Sales, Revenue and Gross Margin (2014-2019)
        11.3.4 China Isotope & Radiation Therapeutic Nuclear Medicines Products Offered
        11.3.5 China Isotope & Radiation Recent Development
    11.4 Dongcheng
        11.4.1 Dongcheng Company Details
        11.4.2 Company Business Overview
        11.4.3 Dongcheng Therapeutic Nuclear Medicines Sales, Revenue and Gross Margin (2014-2019)
        11.4.4 Dongcheng Therapeutic Nuclear Medicines Products Offered
        11.4.5 Dongcheng Recent Development
    11.5 Q BioMed
        11.5.1 Q BioMed Company Details
        11.5.2 Company Business Overview
        11.5.3 Q BioMed Therapeutic Nuclear Medicines Sales, Revenue and Gross Margin (2014-2019)
        11.5.4 Q BioMed Therapeutic Nuclear Medicines Products Offered
        11.5.5 Q BioMed Recent Development
    11.6 Curium Pharmaceuticals
        11.6.1 Curium Pharmaceuticals Company Details
        11.6.2 Company Business Overview
        11.6.3 Curium Pharmaceuticals Therapeutic Nuclear Medicines Sales, Revenue and Gross Margin (2014-2019)
        11.6.4 Curium Pharmaceuticals Therapeutic Nuclear Medicines Products Offered
        11.6.5 Curium Pharmaceuticals Recent Development
    11.7 Jubilant DraxImage
        11.7.1 Jubilant DraxImage Company Details
        11.7.2 Company Business Overview
        11.7.3 Jubilant DraxImage Therapeutic Nuclear Medicines Sales, Revenue and Gross Margin (2014-2019)
        11.7.4 Jubilant DraxImage Therapeutic Nuclear Medicines Products Offered
        11.7.5 Jubilant DraxImage Recent Development
    11.8 Lantheus
        11.8.1 Lantheus Company Details
        11.8.2 Company Business Overview
        11.8.3 Lantheus Therapeutic Nuclear Medicines Sales, Revenue and Gross Margin (2014-2019)
        11.8.4 Lantheus Therapeutic Nuclear Medicines Products Offered
        11.8.5 Lantheus Recent Development
    11.9 Spectrum Pharmaceuticals
        11.9.1 Spectrum Pharmaceuticals Company Details
        11.9.2 Company Business Overview
        11.9.3 Spectrum Pharmaceuticals Therapeutic Nuclear Medicines Sales, Revenue and Gross Margin (2014-2019)
        11.9.4 Spectrum Pharmaceuticals Therapeutic Nuclear Medicines Products Offered
        11.9.5 Spectrum Pharmaceuticals Recent Development
    11.10 Progenics Pharmaceuticals
        11.10.1 Progenics Pharmaceuticals Company Details
        11.10.2 Company Business Overview
        11.10.3 Progenics Pharmaceuticals Therapeutic Nuclear Medicines Sales, Revenue and Gross Margin (2014-2019)
        11.10.4 Progenics Pharmaceuticals Therapeutic Nuclear Medicines Products Offered
        11.10.5 Progenics Pharmaceuticals Recent Development
    11.11 International Isotopes

12 Future Forecast
    12.1 Therapeutic Nuclear Medicines Market Forecast by Regions
        12.1.1 Global Therapeutic Nuclear Medicines Sales Forecast by Regions 2019-2025
        12.1.2 Global Therapeutic Nuclear Medicines Revenue Forecast by Regions 2019-2025
    12.2 Therapeutic Nuclear Medicines Market Forecast by Type
        12.2.1 Global Therapeutic Nuclear Medicines Sales Forecast by Type 2019-2025
        12.2.2 Global Therapeutic Nuclear Medicines Revenue Forecast by Type 2019-2025
    12.3 Therapeutic Nuclear Medicines Market Forecast by Application
    12.4 North America Therapeutic Nuclear Medicines Forecast
    12.5 Europe Therapeutic Nuclear Medicines Forecast
    12.6 Asia Pacific Therapeutic Nuclear Medicines Forecast
    12.7 Central & South America Therapeutic Nuclear Medicines Forecast
    12.8 Middle East and Africa Therapeutic Nuclear Medicines Forecast

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
    13.1 Market Opportunities and Drivers
    13.2 Market Challenges
    13.3 Market Risks/Restraints
    13.4 Macroscopic Indicators

14 Value Chain and Sales Channels Analysis
    14.1 Value Chain Analysis
    14.2 Therapeutic Nuclear Medicines Customers
    14.3 Sales Channels Analysis
        14.3.1 Sales Channels
        14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
    16.1 Research Methodology
        16.1.1 Methodology/Research Approach
        16.1.2 Data Source
    16.2 Author Details
    16.3 Disclaimer
List of Tables and Figures

    Figure Therapeutic Nuclear Medicines Product Picture
    Table Therapeutic Nuclear Medicines Market Segments
    Table Key Manufacturers Therapeutic Nuclear Medicines Covered
    Table Global Therapeutic Nuclear Medicines Market Size Growth Rate by Type 2019-2025 (K Units) & (Million US$)
    Figure Global Therapeutic Nuclear Medicines Sales Market Share by Type in 2018 & 2025
    Figure Radium-223 Product Picture
    Table Major Manufacturers of Radium-223
    Figure Lutetium-177 Product Picture
    Table Major Manufacturers of Lutetium-177
    Figure Iodine-131 Product Picture
    Table Major Manufacturers of Iodine-131
    Figure Other Product Picture
    Table Major Manufacturers of Other
    Table Global Therapeutic Nuclear Medicines Market Size Growth Rate by Application 2019-2025 (K Units)
    Figure Global Therapeutic Nuclear Medicines 4900 Sales Market Share by Application in 2018
    Figure Thyroid
    Figure Bone Metastasis
    Figure Lymphoma
    Figure Other
    Figure Therapeutic Nuclear Medicines Report Years Considered
    Figure Global Therapeutic Nuclear Medicines Market Size 2014-2025 (Million US$)
    Figure Global Therapeutic Nuclear Medicines Sales 2014-2025 (K Units)
    Table Global Therapeutic Nuclear Medicines Market Size by Regions 2014-2019 (K Units) & (Million US$)
    Table Global Therapeutic Nuclear Medicines Sales by Regions 2014-2019 (K Units)
    Table Global Therapeutic Nuclear Medicines Sales Market Share by Regions 2014-2019
    Figure Global Therapeutic Nuclear Medicines Sales Market Share by Regions 2014-2019
    Figure 2018 Global Therapeutic Nuclear Medicines Sales Market Share by Regions
    Table Global Therapeutic Nuclear Medicines Revenue by Regions 2014-2019 (Million US$)
    Table Global Therapeutic Nuclear Medicines Revenue Market Share by Regions 2014-2019
    Figure Global Therapeutic Nuclear Medicines Revenue Market Share by Regions 2014-2019
    Figure 2018 Global Therapeutic Nuclear Medicines Revenue Market Share by Regions
    Table Global Therapeutic Nuclear Medicines Sales by Manufacturers (2014-2019) (K Units)
    Table Global Therapeutic Nuclear Medicines Sales Share by Manufacturers (2014-2019)
    Figure Global Therapeutic Nuclear Medicines Sales Share by Manufacturers in 2018
    Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table Therapeutic Nuclear Medicines Revenue by Manufacturers (2014-2019) (Million USD)
    Table Therapeutic Nuclear Medicines Revenue Share by Manufacturers (2014-2019)
    Figure Therapeutic Nuclear Medicines Value Share by Manufacturers in 2018
    Table Key Manufacturers Therapeutic Nuclear Medicines Price (2014-2019) (USD/Unit)
    Table Therapeutic Nuclear Medicines Manufacturers Manufacturing Base Distribution and Headquarters
    Table Manufacturers Therapeutic Nuclear Medicines Product Type
    Table Date of International Manufacturers Enter into Therapeutic Nuclear Medicines Market
    Table Manufacturers Mergers & Acquisitions, Expansion Plans
    Table Global Therapeutic Nuclear Medicines Sales by Type (2014-2019) (K Units)
    Table Global Therapeutic Nuclear Medicines Sales Share by Type (2014-2019)
    Figure Global Therapeutic Nuclear Medicines Sales Market Share by Type (2014-2019)
    Figure Global Therapeutic Nuclear Medicines Sales Market Share by Type in 2018
    Table Global Therapeutic Nuclear Medicines Revenue by Type (2014-2019) (Million US$)
    Table Global Therapeutic Nuclear Medicines Revenue Share by Type (2014-2019)
    Figure Global Therapeutic Nuclear Medicines Revenue Market Share by Type (2014-2019)
    Figure Global Therapeutic Nuclear Medicines Revenue Market Share by Type in 2018
    Table Therapeutic Nuclear Medicines Price by Type 2014-2019 (USD/Unit)
    Table Global Therapeutic Nuclear Medicines Sales by Application (2014-2019) (K Units)
    Table Global Therapeutic Nuclear Medicines Sales Share by Application (2014-2019)
    Figure Global Sales Therapeutic Nuclear Medicines Market Share by Application (2014-2019)
    Figure Global Sales Therapeutic Nuclear Medicines Market Share by Application in 2018
    Figure North America Therapeutic Nuclear Medicines Sales Growth Rate 2014-2019 (K Units)
    Figure North America Therapeutic Nuclear Medicines Revenue Growth Rate 2014-2019 (Million US$)
    Table North America Therapeutic Nuclear Medicines Sales by Country (2014-2019) (K Units)
    Table North America Therapeutic Nuclear Medicines Sales Market Share by Country (2014-2019)
    Figure 2018 North America Therapeutic Nuclear Medicines Sales Market Share by Country
    Table North America Therapeutic Nuclear Medicines Revenue by Country (2014-2019) (Million US$)
    Table North America Therapeutic Nuclear Medicines Revenue Market Share by Country (2014-2019)
    Figure 2018 North America Therapeutic Nuclear Medicines Revenue Market Share by Country
    Figure United States Therapeutic Nuclear Medicines Sales Growth Rate (2014-2019) (K Units)
    Figure United States Therapeutic Nuclear Medicines Revenue Growth Rate (2014-2019) (K Units)
    Figure Canada Therapeutic Nuclear Medicines Sales Growth Rate (2014-2019) (K Units)
    Figure Canada Therapeutic Nuclear Medicines Revenue Growth Rate (2014-2019) (Million US$)
    Figure Mexico Therapeutic Nuclear Medicines Sales Growth Rate (2014-2019) (K Units)
    Figure Mexico Therapeutic Nuclear Medicines Revenue Growth Rate (2014-2019) (Million US$)
    Table North America Therapeutic Nuclear Medicines Sales by Type (2014-2019) (K Units)
    Table North America Therapeutic Nuclear Medicines Sales Market Share by Type (2014-2019)
    Figure 2018 North America Therapeutic Nuclear Medicines Market Share by Type
    Table North America Therapeutic Nuclear Medicines Sales by Application (2014-2019) (K Units)
    Table North America Therapeutic Nuclear Medicines Sales Market Share by Application (2014-2019)
    Figure 2018 North America Therapeutic Nuclear Medicines Market Share by Application
    Figure Europe Therapeutic Nuclear Medicines Sales Growth Rate 2014-2019 (K Units)
    Figure Europe Therapeutic Nuclear Medicines Revenue Growth Rate 2014-2019 (Million US$)
    Table Europe Therapeutic Nuclear Medicines Sales by Country (2014-2019) (K Units)
    Table Europe Therapeutic Nuclear Medicines Sales Market Share by Country (2014-2019)
    Figure 2018 Europe Therapeutic Nuclear Medicines Sales Market Share by Country
    Table Europe Therapeutic Nuclear Medicines Revenue by Country (2014-2019) (Million US$)
    Table Europe Therapeutic Nuclear Medicines Revenue Market Share by Country (2014-2019)
    Figure 2018 Europe Therapeutic Nuclear Medicines Revenue Market Share by Country
    Figure Germany Therapeutic Nuclear Medicines Sales Growth Rate (2014-2019) (K Units)
    Figure Germany Therapeutic Nuclear Medicines Revenue Growth Rate (2014-2019) (Million US$)
    Figure France Therapeutic Nuclear Medicines Sales Growth Rate (2014-2019) (K Units)
    Figure France Therapeutic Nuclear Medicines Revenue Growth Rate (2014-2019) (Million US$)
    Figure UK Therapeutic Nuclear Medicines Sales Growth Rate (2014-2019) (K Units)
    Figure UK Therapeutic Nuclear Medicines Revenue Growth Rate (2014-2019) (Million US$)
    Figure Italy Therapeutic Nuclear Medicines Sales Growth Rate (2014-2019) (K Units)
    Figure Italy Therapeutic Nuclear Medicines Revenue Growth Rate (2014-2019) (Million US$)
    Figure Russia Therapeutic Nuclear Medicines Sales Growth Rate (2014-2019) (K Units)
    Figure Russia Therapeutic Nuclear Medicines Revenue Growth Rate (2014-2019) (Million US$)
    Table Europe Therapeutic Nuclear Medicines Sales by Type (2014-2019) (K Units)
    Table Europe Therapeutic Nuclear Medicines Sales Market Share by Type (2014-2019)
    Figure 2018 Europe Therapeutic Nuclear Medicines Market Share by Type
    Table Europe Therapeutic Nuclear Medicines Sales by Application (2014-2019) (K Units)
    Table Europe Therapeutic Nuclear Medicines Sales Market Share by Application (2014-2019)
    Figure 2018 Europe Therapeutic Nuclear Medicines Market Share by Application
    Figure Asia Pacific Therapeutic Nuclear Medicines Sales Growth Rate 2014-2019 (K Units)
    Figure Asia Pacific Therapeutic Nuclear Medicines Revenue Growth Rate 2014-2019 (Million US$)
    Table Asia Pacific Therapeutic Nuclear Medicines Sales by Country (2014-2019) (K Units)
    Table Asia Pacific Therapeutic Nuclear Medicines Sales Market Share by Country (2014-2019)
    Figure 2018 Asia Pacific Therapeutic Nuclear Medicines Sales Market Share by Country
    Table Asia Pacific Therapeutic Nuclear Medicines Revenue by Country (2014-2019) (Million US$)
    Table Asia Pacific Therapeutic Nuclear Medicines Revenue Market Share by Country (2014-2019)
    Figure 2018 Asia Pacific Therapeutic Nuclear Medicines Revenue Market Share by Country
    Figure China Therapeutic Nuclear Medicines Sales Growth Rate (2014-2019) (K Units)
    Figure China Therapeutic Nuclear Medicines Revenue Growth Rate (2014-2019) (Million US$)
    Figure Japan Therapeutic Nuclear Medicines Sales Growth Rate (2014-2019) (K Units)
    Figure Japan Therapeutic Nuclear Medicines Revenue Growth Rate (2014-2019) (Million US$)
    Figure Korea Therapeutic Nuclear Medicines Sales Growth Rate (2014-2019) (K Units)
    Figure Korea Therapeutic Nuclear Medicines Revenue Growth Rate (2014-2019) (Million US$)
    Figure India Therapeutic Nuclear Medicines Sales Growth Rate (2014-2019) (K Units)
    Figure India Therapeutic Nuclear Medicines Revenue Growth Rate (2014-2019) (Million US$)
    Figure Australia Therapeutic Nuclear Medicines Sales Growth Rate (2014-2019) (K Units)
    Figure Australia Therapeutic Nuclear Medicines Revenue Growth Rate (2014-2019) (Million US$)
    Figure Indonesia Therapeutic Nuclear Medicines Sales Growth Rate (2014-2019) (K Units)
    Figure Indonesia Therapeutic Nuclear Medicines Revenue Growth Rate (2014-2019) (Million US$)
    Figure Malaysia Therapeutic Nuclear Medicines Sales Growth Rate (2014-2019) (K Units)
    Figure Malaysia Therapeutic Nuclear Medicines Revenue Growth Rate (2014-2019) (Million US$)
    Figure Philippines Therapeutic Nuclear Medicines Sales Growth Rate (2014-2019) (K Units)
    Figure Philippines Therapeutic Nuclear Medicines Revenue Growth Rate (2014-2019) (Million US$)
    Figure Thailand Therapeutic Nuclear Medicines Sales Growth Rate (2014-2019) (K Units)
    Figure Thailand Therapeutic Nuclear Medicines Revenue Growth Rate (2014-2019) (Million US$)
    Figure Vietnam Therapeutic Nuclear Medicines Sales Growth Rate (2014-2019) (K Units)
    Figure Vietnam Therapeutic Nuclear Medicines Revenue Growth Rate (2014-2019) (Million US$)
    Figure Singapore Therapeutic Nuclear Medicines Sales Growth Rate (2014-2019) (K Units)
    Figure Singapore Therapeutic Nuclear Medicines Revenue Growth Rate (2014-2019) (Million US$)
    Table Asia Pacific Therapeutic Nuclear Medicines Sales by Type (2014-2019) (K Units)
    Table Asia Pacific Therapeutic Nuclear Medicines Sales Market Share by Type (2014-2019)
    Figure 2018 Asia Pacific Therapeutic Nuclear Medicines Market Share by Type
    Table Asia Pacific Therapeutic Nuclear Medicines Sales by Application (2014-2019) (K Units)
    Table Asia Pacific Therapeutic Nuclear Medicines Sales Market Share by Application (2014-2019)
    Figure 2018 Asia Pacific Therapeutic Nuclear Medicines Market Share by Application
    Figure Central & South America Therapeutic Nuclear Medicines Sales Growth Rate 2014-2019 (K Units)
    Figure Central & South America Therapeutic Nuclear Medicines Revenue Growth Rate 2014-2019 (Million US$)
    Table Central & South America Therapeutic Nuclear Medicines Sales by Country (2014-2019) (K Units)
    Table Central & South America Therapeutic Nuclear Medicines Sales Market Share by Country (2014-2019)
    Figure 2018 Central & South America Therapeutic Nuclear Medicines Sales Market Share by Country
    Table Central & South America Therapeutic Nuclear Medicines Revenue by Country (2014-2019) (Million US$)
    Table Central & South America Therapeutic Nuclear Medicines Revenue Market Share by Country (2014-2019)
    Figure 2018 Central & South America Therapeutic Nuclear Medicines Revenue Market Share by Country
    Figure Brazil Therapeutic Nuclear Medicines Sales Growth Rate (2014-2019) (K Units)
    Figure Brazil Therapeutic Nuclear Medicines Revenue Growth Rate (2014-2019) (Million US$)
    Figure Argentina Therapeutic Nuclear Medicines Sales Growth Rate (2014-2019) (K Units)
    Figure Argentina Therapeutic Nuclear Medicines Revenue Growth Rate (2014-2019) (Million US$)
    Table Central & South America Therapeutic Nuclear Medicines Sales by Type (2014-2019) (K Units)
    Table Central & South America Therapeutic Nuclear Medicines Sales Market Share by Type (2014-2019)
    Figure 2018 Central & South America Therapeutic Nuclear Medicines Market Share by Type
    Table Central & South America Therapeutic Nuclear Medicines Sales by Application (2014-2019) (K Units)
    Table Central & South America Therapeutic Nuclear Medicines Sales Market Share by Application (2014-2019)
    Figure 2018 Central & South America Therapeutic Nuclear Medicines Market Share by Application
    Figure Middle East and Africa Therapeutic Nuclear Medicines Sales Growth Rate 2014-2019 (K Units)
    Figure Middle East and Africa Therapeutic Nuclear Medicines Revenue Growth Rate 2014-2019 (Million US$)
    Table Middle East and Africa Therapeutic Nuclear Medicines Sales by Country (2014-2019) (K Units)
    Table Middle East and Africa Therapeutic Nuclear Medicines Sales Market Share by Country (2014-2019)
    Figure 2018 Middle East and Africa Therapeutic Nuclear Medicines Sales Market Share by Country
    Table Middle East and Africa Therapeutic Nuclear Medicines Revenue by Country (2014-2019) (Million US$)
    Table Middle East and Africa Therapeutic Nuclear Medicines Revenue Market Share by Country (2014-2019)
    Figure 2018 Middle East and Africa Therapeutic Nuclear Medicines Revenue Market Share by Country
    Figure GCC Countries Therapeutic Nuclear Medicines Sales Growth Rate (2014-2019) (K Units)
    Figure GCC Countries Therapeutic Nuclear Medicines Revenue Growth Rate (2014-2019) (Million US$)
    Figure Turkey Therapeutic Nuclear Medicines Sales Growth Rate (2014-2019) (K Units)
    Figure Turkey Therapeutic Nuclear Medicines Revenue Growth Rate (2014-2019) (Million US$)
    Figure Egypt Therapeutic Nuclear Medicines Sales Growth Rate (2014-2019) (K Units)
    Figure Egypt Therapeutic Nuclear Medicines Revenue Growth Rate (2014-2019) (Million US$)
    Figure South Africa Therapeutic Nuclear Medicines Sales Growth Rate (2014-2019) (K Units)
    Figure South Africa Therapeutic Nuclear Medicines Revenue Growth Rate (2014-2019) (Million US$)
    Table Middle East and Africa Therapeutic Nuclear Medicines Sales by Type (2014-2019) (K Units)
    Table Middle East and Africa Therapeutic Nuclear Medicines Sales Market Share by Type (2014-2019)
    Figure 2018 Middle East and Africa Therapeutic Nuclear Medicines Market Share by Type
    Table Middle East and Africa Therapeutic Nuclear Medicines Sales by Application (2014-2019) (K Units)
    Table Middle East and Africa Therapeutic Nuclear Medicines Sales Market Share by Application (2014-2019)
    Figure 2018 Middle East and Africa Therapeutic Nuclear Medicines Market Share by Application
    Table Bayer Company Details
    Table Bayer Therapeutic Nuclear Medicines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
    Table Bayer Recent Development
    Table Novartis AG Company Details
    Table Novartis AG Therapeutic Nuclear Medicines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
    Table Novartis AG Recent Development
    Table China Isotope & Radiation Company Details
    Table China Isotope & Radiation Therapeutic Nuclear Medicines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
    Table China Isotope & Radiation Recent Development
    Table Dongcheng Company Details
    Table Dongcheng Therapeutic Nuclear Medicines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
    Table Dongcheng Recent Development
    Table Q BioMed Company Details
    Table Q BioMed Therapeutic Nuclear Medicines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
    Table Q BioMed Recent Development
    Table Curium Pharmaceuticals Company Details
    Table Curium Pharmaceuticals Therapeutic Nuclear Medicines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
    Table Curium Pharmaceuticals Recent Development
    Table Jubilant DraxImage Company Details
    Table Jubilant DraxImage Therapeutic Nuclear Medicines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
    Table Jubilant DraxImage Recent Development
    Table Lantheus Company Details
    Table Lantheus Therapeutic Nuclear Medicines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
    Table Lantheus Recent Development
    Table Spectrum Pharmaceuticals Company Details
    Table Spectrum Pharmaceuticals Therapeutic Nuclear Medicines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
    Table Spectrum Pharmaceuticals Recent Development
    Table Progenics Pharmaceuticals Company Details
    Table Progenics Pharmaceuticals Therapeutic Nuclear Medicines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
    Table Progenics Pharmaceuticals Recent Development
    Table International Isotopes Company Details
    Table Global Therapeutic Nuclear Medicines Sales Forecast by Regions 2019-2025 (K Units)
    Table Global Therapeutic Nuclear Medicines Sales Market Share Forecast by Regions 2019-2025
    Table Global Therapeutic Nuclear Medicines Revenue Forecast by Regions 2019-2025 (Million US$)
    Table Global Therapeutic Nuclear Medicines Revenue Market Share Forecast by Regions 2019-2025
    Table Global Therapeutic Nuclear Medicines Sales Forecast by Type 2019-2025 (K Units)
    Table Global Therapeutic Nuclear Medicines Sales Market Share Forecast by Type 2019-2025
    Table Global Therapeutic Nuclear Medicines Revenue Forecast by Type 2019-2025 (Million US$)
    Table Global Therapeutic Nuclear Medicines Revenue Market Share Forecast by Type 2019-2025
    Table Global Therapeutic Nuclear Medicines Sales Forecast by Application 2019-2025 (K Units)
    Table Global Therapeutic Nuclear Medicines Sales Market Share Forecast by Application 2019-2025
    Figure North America Therapeutic Nuclear Medicines Sales Growth Rate Forecast (2019-2025) (K Units)
    Figure North America Therapeutic Nuclear Medicines Revenue Growth Rate Forecast (2019-2025) (Million US$)
    Figure Europe Therapeutic Nuclear Medicines Sales Growth Rate Forecast (2019-2025) (K Units)
    Figure Europe Therapeutic Nuclear Medicines Revenue Growth Rate Forecast (2019-2025) (Million US$)
    Figure Asia Pacific Therapeutic Nuclear Medicines Sales Growth Rate Forecast (2019-2025) (K Units)
    Figure Asia Pacific Therapeutic Nuclear Medicines Revenue Growth Rate Forecast (2019-2025) (Million US$)
    Figure Central & South America Therapeutic Nuclear Medicines Sales Growth Rate Forecast (2019-2025) (K Units)
    Figure Central & South America Therapeutic Nuclear Medicines Revenue Growth Rate Forecast (2019-2025) (Million US$)
    Figure Middle East and Africa Therapeutic Nuclear Medicines Sales Growth Rate Forecast (2019-2025) (K Units)
    Figure Middle East and Africa Therapeutic Nuclear Medicines Revenue Growth Rate Forecast (2019-2025) (Million US$)
    Table Key Opportunities and Drivers: Impact Analysis (2019-2025)
    Table Key Challenges
    Table Market Risks
    Figure Porter's Five Forces Analysis
    Table Therapeutic Nuclear Medicines Value Chain
    Table Therapeutic Nuclear Medicines Customers List
    Figure Channels of Distribution
    Table Therapeutic Nuclear Medicines Distributors List
    Figure Distributors Profiles
    Table Research Programs/Design for This Report
    Figure Bottom-up and Top-down Approaches for This Report
    Figure Data Triangulation
    Figure Key Executives Interviewed
    Table Key Data Information from Secondary Sources
    Table Key Data Information from Primary Sources
Radioactive material, called radiopharmaceuticals, can be used to treat certain conditions. This is called nuclear medicine therapy. Therapeutic nuclear medicines are a pharmaceutical formulation that consists of radioactive substances (radioisotopes). Therapeutic nuclear medicines are intending for the treatment of cancer, metastatic bone pain and other diseases. The radioactive material of therapeutic nuclear medicines is capable of killing the cancerous tissue, reducing the size of a tumor and reducing pain.
Radioactive material, called radiopharmaceuticals, can be used to treat certain conditions. This is called nuclear medicine therapy.
North Americas is the largest consumption place, with a revenue market share nearly 44.8% in 2018. Following North Americas, Europe is the second largest consumption place with the revenue market share of 29% in 2018.
The global Therapeutic Nuclear Medicines market is valued at 855 million US$ in 2018 and will reach 2723.6 million US$ by the end of 2025, growing at a CAGR of 18.0% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Therapeutic Nuclear Medicines market based on company, product type, end user and key regions.

This report studies the global market size of Therapeutic Nuclear Medicines in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Therapeutic Nuclear Medicines in these regions.
This research report categorizes the global Therapeutic Nuclear Medicines market by top players/brands, region, type and end user. This report also studies the global Therapeutic Nuclear Medicines market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:
    Bayer
    Novartis AG
    China Isotope & Radiation
    Dongcheng
    Q BioMed
    Curium Pharmaceuticals
    Jubilant DraxImage
    Lantheus
    Spectrum Pharmaceuticals
    Progenics Pharmaceuticals
    International Isotopes

Therapeutic Nuclear Medicines market size by Type
    Radium-223
    Lutetium-177
    Iodine-131
    Other
Therapeutic Nuclear Medicines market size by Applications
    Thyroid
    Bone Metastasis
    Lymphoma
    Other

Market size by Region
    North America
        United States
        Canada
        Mexico
    Asia-Pacific
        China
        Japan
        South Korea
        India
        Australia
        Indonesia
        Thailand
        Malaysia
        Philippines
        Vietnam
    Europe
        Germany
        France
        UK
        Italy
        Spain
        Russia
    Central & South America
        Brazil
        Rest of Central & South America
    Middle East & Africa
        Turkey
        GCC Countries
        Egypt
        South Africa

The study objectives of this report are:
    To study and analyze the global Therapeutic Nuclear Medicines market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
    To understand the structure of Therapeutic Nuclear Medicines market by identifying its various subsegments.
    To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
    Focuses on the key global Therapeutic Nuclear Medicines companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
    To project the value and sales volume of Therapeutic Nuclear Medicines submarkets, with respect to key regions.
    To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Therapeutic Nuclear Medicines are as follows:
    History Year: 2014-2018
    Base Year: 2018
    Estimated Year: 2019
    Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Therapeutic Nuclear Medicines market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Read More
Table of Contents

1 Study Coverage
    1.1 Therapeutic Nuclear Medicines Product Introduction
    1.2 Market Segments
    1.3 Key Manufacturers Covered
    1.4 Market by Type
        1.4.1 Global Therapeutic Nuclear Medicines Market Size Growth Rate by Type
        1.4.2 Radium-223
        1.4.3 Lutetium-177
        1.4.4 Iodine-131
        1.4.5 Other
    1.5 Market by Application
        1.5.1 Global Therapeutic Nuclear Medicines Market Size Growth Rate by Application
        1.5.2 Thyroid
        1.5.3 Bone Metastasis
        1.5.4 Lymphoma
        1.5.5 Other
    1.6 Study Objectives
    1.7 Years Considered

2 Executive Summary
    2.1 Global Therapeutic Nuclear Medicines Market Size
        2.1.1 Global Therapeutic Nuclear Medicines Revenue 2014-2025
        2.1.2 Global Therapeutic Nuclear Medicines Sales 2014-2025
    2.2 Therapeutic Nuclear Medicines Growth Rate by Regions
        2.2.1 Global Therapeutic Nuclear Medicines Sales by Regions
        2.2.2 Global Therapeutic Nuclear Medicines Revenue by Regions

3 Breakdown Data by Manufacturers
    3.1 Therapeutic Nuclear Medicines Sales by Manufacturers
        3.1.1 Therapeutic Nuclear Medicines Sales by Manufacturers
        3.1.2 Therapeutic Nuclear Medicines Sales Market Share by Manufacturers
    3.2 Therapeutic Nuclear Medicines Revenue by Manufacturers
        3.2.1 Therapeutic Nuclear Medicines Revenue by Manufacturers (2014-2019)
        3.2.2 Therapeutic Nuclear Medicines Revenue Share by Manufacturers (2014-2019)
    3.3 Therapeutic Nuclear Medicines Price by Manufacturers
    3.4 Therapeutic Nuclear Medicines Manufacturing Base Distribution, Product Types
        3.4.1 Therapeutic Nuclear Medicines Manufacturers Manufacturing Base Distribution, Headquarters
        3.4.2 Manufacturers Therapeutic Nuclear Medicines Product Type
        3.4.3 Date of International Manufacturers Enter into Therapeutic Nuclear Medicines Market
    3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type
    4.1 Global Therapeutic Nuclear Medicines Sales by Type
    4.2 Global Therapeutic Nuclear Medicines Revenue by Type
    4.3 Therapeutic Nuclear Medicines Price by Type

5 Breakdown Data by Application
    5.1 Overview
    5.2 Global Therapeutic Nuclear Medicines Breakdown Data by Application

6 North America
    6.1 North America Therapeutic Nuclear Medicines by Country
        6.1.1 North America Therapeutic Nuclear Medicines Sales by Country
        6.1.2 North America Therapeutic Nuclear Medicines Revenue by Country
        6.1.3 United States
        6.1.4 Canada
        6.1.5 Mexico
    6.2 North America Therapeutic Nuclear Medicines by Type
    6.3 North America Therapeutic Nuclear Medicines by Application

7 Europe
    7.1 Europe Therapeutic Nuclear Medicines by Country
        7.1.1 Europe Therapeutic Nuclear Medicines Sales by Country
        7.1.2 Europe Therapeutic Nuclear Medicines Revenue by Country
        7.1.3 Germany
        7.1.4 France
        7.1.5 UK
        7.1.6 Italy
        7.1.7 Russia
    7.2 Europe Therapeutic Nuclear Medicines by Type
    7.3 Europe Therapeutic Nuclear Medicines by Application

8 Asia Pacific
    8.1 Asia Pacific Therapeutic Nuclear Medicines by Country
        8.1.1 Asia Pacific Therapeutic Nuclear Medicines Sales by Country
        8.1.2 Asia Pacific Therapeutic Nuclear Medicines Revenue by Country
        8.1.3 China
        8.1.4 Japan
        8.1.5 Korea
        8.1.6 India
        8.1.7 Australia
        8.1.8 Indonesia
        8.1.9 Malaysia
        8.1.10 Philippines
        8.1.11 Thailand
        8.1.12 Vietnam
        8.1.13 Singapore
    8.2 Asia Pacific Therapeutic Nuclear Medicines by Type
    8.3 Asia Pacific Therapeutic Nuclear Medicines by Application

9 Central & South America
    9.1 Central & South America Therapeutic Nuclear Medicines by Country
        9.1.1 Central & South America Therapeutic Nuclear Medicines Sales by Country
        9.1.2 Central & South America Therapeutic Nuclear Medicines Revenue by Country
        9.1.3 Brazil
        9.1.4 Argentina
    9.2 Central & South America Therapeutic Nuclear Medicines by Type
    9.3 Central & South America Therapeutic Nuclear Medicines by Application

10 Middle East and Africa
    10.1 Middle East and Africa Therapeutic Nuclear Medicines by Country
        10.1.1 Middle East and Africa Therapeutic Nuclear Medicines Sales by Country
        10.1.2 Middle East and Africa Therapeutic Nuclear Medicines Revenue by Country
        10.1.3 GCC Countries
        10.1.4 Turkey
        10.1.5 Egypt
        10.1.6 South Africa
    10.2 Middle East and Africa Therapeutic Nuclear Medicines by Type
    10.3 Middle East and Africa Therapeutic Nuclear Medicines by Application

11 Company Profiles
    11.1 Bayer
        11.1.1 Bayer Company Details
        11.1.2 Company Business Overview
        11.1.3 Bayer Therapeutic Nuclear Medicines Sales, Revenue and Gross Margin (2014-2019)
        11.1.4 Bayer Therapeutic Nuclear Medicines Products Offered
        11.1.5 Bayer Recent Development
    11.2 Novartis AG
        11.2.1 Novartis AG Company Details
        11.2.2 Company Business Overview
        11.2.3 Novartis AG Therapeutic Nuclear Medicines Sales, Revenue and Gross Margin (2014-2019)
        11.2.4 Novartis AG Therapeutic Nuclear Medicines Products Offered
        11.2.5 Novartis AG Recent Development
    11.3 China Isotope & Radiation
        11.3.1 China Isotope & Radiation Company Details
        11.3.2 Company Business Overview
        11.3.3 China Isotope & Radiation Therapeutic Nuclear Medicines Sales, Revenue and Gross Margin (2014-2019)
        11.3.4 China Isotope & Radiation Therapeutic Nuclear Medicines Products Offered
        11.3.5 China Isotope & Radiation Recent Development
    11.4 Dongcheng
        11.4.1 Dongcheng Company Details
        11.4.2 Company Business Overview
        11.4.3 Dongcheng Therapeutic Nuclear Medicines Sales, Revenue and Gross Margin (2014-2019)
        11.4.4 Dongcheng Therapeutic Nuclear Medicines Products Offered
        11.4.5 Dongcheng Recent Development
    11.5 Q BioMed
        11.5.1 Q BioMed Company Details
        11.5.2 Company Business Overview
        11.5.3 Q BioMed Therapeutic Nuclear Medicines Sales, Revenue and Gross Margin (2014-2019)
        11.5.4 Q BioMed Therapeutic Nuclear Medicines Products Offered
        11.5.5 Q BioMed Recent Development
    11.6 Curium Pharmaceuticals
        11.6.1 Curium Pharmaceuticals Company Details
        11.6.2 Company Business Overview
        11.6.3 Curium Pharmaceuticals Therapeutic Nuclear Medicines Sales, Revenue and Gross Margin (2014-2019)
        11.6.4 Curium Pharmaceuticals Therapeutic Nuclear Medicines Products Offered
        11.6.5 Curium Pharmaceuticals Recent Development
    11.7 Jubilant DraxImage
        11.7.1 Jubilant DraxImage Company Details
        11.7.2 Company Business Overview
        11.7.3 Jubilant DraxImage Therapeutic Nuclear Medicines Sales, Revenue and Gross Margin (2014-2019)
        11.7.4 Jubilant DraxImage Therapeutic Nuclear Medicines Products Offered
        11.7.5 Jubilant DraxImage Recent Development
    11.8 Lantheus
        11.8.1 Lantheus Company Details
        11.8.2 Company Business Overview
        11.8.3 Lantheus Therapeutic Nuclear Medicines Sales, Revenue and Gross Margin (2014-2019)
        11.8.4 Lantheus Therapeutic Nuclear Medicines Products Offered
        11.8.5 Lantheus Recent Development
    11.9 Spectrum Pharmaceuticals
        11.9.1 Spectrum Pharmaceuticals Company Details
        11.9.2 Company Business Overview
        11.9.3 Spectrum Pharmaceuticals Therapeutic Nuclear Medicines Sales, Revenue and Gross Margin (2014-2019)
        11.9.4 Spectrum Pharmaceuticals Therapeutic Nuclear Medicines Products Offered
        11.9.5 Spectrum Pharmaceuticals Recent Development
    11.10 Progenics Pharmaceuticals
        11.10.1 Progenics Pharmaceuticals Company Details
        11.10.2 Company Business Overview
        11.10.3 Progenics Pharmaceuticals Therapeutic Nuclear Medicines Sales, Revenue and Gross Margin (2014-2019)
        11.10.4 Progenics Pharmaceuticals Therapeutic Nuclear Medicines Products Offered
        11.10.5 Progenics Pharmaceuticals Recent Development
    11.11 International Isotopes

12 Future Forecast
    12.1 Therapeutic Nuclear Medicines Market Forecast by Regions
        12.1.1 Global Therapeutic Nuclear Medicines Sales Forecast by Regions 2019-2025
        12.1.2 Global Therapeutic Nuclear Medicines Revenue Forecast by Regions 2019-2025
    12.2 Therapeutic Nuclear Medicines Market Forecast by Type
        12.2.1 Global Therapeutic Nuclear Medicines Sales Forecast by Type 2019-2025
        12.2.2 Global Therapeutic Nuclear Medicines Revenue Forecast by Type 2019-2025
    12.3 Therapeutic Nuclear Medicines Market Forecast by Application
    12.4 North America Therapeutic Nuclear Medicines Forecast
    12.5 Europe Therapeutic Nuclear Medicines Forecast
    12.6 Asia Pacific Therapeutic Nuclear Medicines Forecast
    12.7 Central & South America Therapeutic Nuclear Medicines Forecast
    12.8 Middle East and Africa Therapeutic Nuclear Medicines Forecast

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
    13.1 Market Opportunities and Drivers
    13.2 Market Challenges
    13.3 Market Risks/Restraints
    13.4 Macroscopic Indicators

14 Value Chain and Sales Channels Analysis
    14.1 Value Chain Analysis
    14.2 Therapeutic Nuclear Medicines Customers
    14.3 Sales Channels Analysis
        14.3.1 Sales Channels
        14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
    16.1 Research Methodology
        16.1.1 Methodology/Research Approach
        16.1.2 Data Source
    16.2 Author Details
    16.3 Disclaimer
Read More
List of Tables and Figures

    Figure Therapeutic Nuclear Medicines Product Picture
    Table Therapeutic Nuclear Medicines Market Segments
    Table Key Manufacturers Therapeutic Nuclear Medicines Covered
    Table Global Therapeutic Nuclear Medicines Market Size Growth Rate by Type 2019-2025 (K Units) & (Million US$)
    Figure Global Therapeutic Nuclear Medicines Sales Market Share by Type in 2018 & 2025
    Figure Radium-223 Product Picture
    Table Major Manufacturers of Radium-223
    Figure Lutetium-177 Product Picture
    Table Major Manufacturers of Lutetium-177
    Figure Iodine-131 Product Picture
    Table Major Manufacturers of Iodine-131
    Figure Other Product Picture
    Table Major Manufacturers of Other
    Table Global Therapeutic Nuclear Medicines Market Size Growth Rate by Application 2019-2025 (K Units)
    Figure Global Therapeutic Nuclear Medicines 4900 Sales Market Share by Application in 2018
    Figure Thyroid
    Figure Bone Metastasis
    Figure Lymphoma
    Figure Other
    Figure Therapeutic Nuclear Medicines Report Years Considered
    Figure Global Therapeutic Nuclear Medicines Market Size 2014-2025 (Million US$)
    Figure Global Therapeutic Nuclear Medicines Sales 2014-2025 (K Units)
    Table Global Therapeutic Nuclear Medicines Market Size by Regions 2014-2019 (K Units) & (Million US$)
    Table Global Therapeutic Nuclear Medicines Sales by Regions 2014-2019 (K Units)
    Table Global Therapeutic Nuclear Medicines Sales Market Share by Regions 2014-2019
    Figure Global Therapeutic Nuclear Medicines Sales Market Share by Regions 2014-2019
    Figure 2018 Global Therapeutic Nuclear Medicines Sales Market Share by Regions
    Table Global Therapeutic Nuclear Medicines Revenue by Regions 2014-2019 (Million US$)
    Table Global Therapeutic Nuclear Medicines Revenue Market Share by Regions 2014-2019
    Figure Global Therapeutic Nuclear Medicines Revenue Market Share by Regions 2014-2019
    Figure 2018 Global Therapeutic Nuclear Medicines Revenue Market Share by Regions
    Table Global Therapeutic Nuclear Medicines Sales by Manufacturers (2014-2019) (K Units)
    Table Global Therapeutic Nuclear Medicines Sales Share by Manufacturers (2014-2019)
    Figure Global Therapeutic Nuclear Medicines Sales Share by Manufacturers in 2018
    Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table Therapeutic Nuclear Medicines Revenue by Manufacturers (2014-2019) (Million USD)
    Table Therapeutic Nuclear Medicines Revenue Share by Manufacturers (2014-2019)
    Figure Therapeutic Nuclear Medicines Value Share by Manufacturers in 2018
    Table Key Manufacturers Therapeutic Nuclear Medicines Price (2014-2019) (USD/Unit)
    Table Therapeutic Nuclear Medicines Manufacturers Manufacturing Base Distribution and Headquarters
    Table Manufacturers Therapeutic Nuclear Medicines Product Type
    Table Date of International Manufacturers Enter into Therapeutic Nuclear Medicines Market
    Table Manufacturers Mergers & Acquisitions, Expansion Plans
    Table Global Therapeutic Nuclear Medicines Sales by Type (2014-2019) (K Units)
    Table Global Therapeutic Nuclear Medicines Sales Share by Type (2014-2019)
    Figure Global Therapeutic Nuclear Medicines Sales Market Share by Type (2014-2019)
    Figure Global Therapeutic Nuclear Medicines Sales Market Share by Type in 2018
    Table Global Therapeutic Nuclear Medicines Revenue by Type (2014-2019) (Million US$)
    Table Global Therapeutic Nuclear Medicines Revenue Share by Type (2014-2019)
    Figure Global Therapeutic Nuclear Medicines Revenue Market Share by Type (2014-2019)
    Figure Global Therapeutic Nuclear Medicines Revenue Market Share by Type in 2018
    Table Therapeutic Nuclear Medicines Price by Type 2014-2019 (USD/Unit)
    Table Global Therapeutic Nuclear Medicines Sales by Application (2014-2019) (K Units)
    Table Global Therapeutic Nuclear Medicines Sales Share by Application (2014-2019)
    Figure Global Sales Therapeutic Nuclear Medicines Market Share by Application (2014-2019)
    Figure Global Sales Therapeutic Nuclear Medicines Market Share by Application in 2018
    Figure North America Therapeutic Nuclear Medicines Sales Growth Rate 2014-2019 (K Units)
    Figure North America Therapeutic Nuclear Medicines Revenue Growth Rate 2014-2019 (Million US$)
    Table North America Therapeutic Nuclear Medicines Sales by Country (2014-2019) (K Units)
    Table North America Therapeutic Nuclear Medicines Sales Market Share by Country (2014-2019)
    Figure 2018 North America Therapeutic Nuclear Medicines Sales Market Share by Country
    Table North America Therapeutic Nuclear Medicines Revenue by Country (2014-2019) (Million US$)
    Table North America Therapeutic Nuclear Medicines Revenue Market Share by Country (2014-2019)
    Figure 2018 North America Therapeutic Nuclear Medicines Revenue Market Share by Country
    Figure United States Therapeutic Nuclear Medicines Sales Growth Rate (2014-2019) (K Units)
    Figure United States Therapeutic Nuclear Medicines Revenue Growth Rate (2014-2019) (K Units)
    Figure Canada Therapeutic Nuclear Medicines Sales Growth Rate (2014-2019) (K Units)
    Figure Canada Therapeutic Nuclear Medicines Revenue Growth Rate (2014-2019) (Million US$)
    Figure Mexico Therapeutic Nuclear Medicines Sales Growth Rate (2014-2019) (K Units)
    Figure Mexico Therapeutic Nuclear Medicines Revenue Growth Rate (2014-2019) (Million US$)
    Table North America Therapeutic Nuclear Medicines Sales by Type (2014-2019) (K Units)
    Table North America Therapeutic Nuclear Medicines Sales Market Share by Type (2014-2019)
    Figure 2018 North America Therapeutic Nuclear Medicines Market Share by Type
    Table North America Therapeutic Nuclear Medicines Sales by Application (2014-2019) (K Units)
    Table North America Therapeutic Nuclear Medicines Sales Market Share by Application (2014-2019)
    Figure 2018 North America Therapeutic Nuclear Medicines Market Share by Application
    Figure Europe Therapeutic Nuclear Medicines Sales Growth Rate 2014-2019 (K Units)
    Figure Europe Therapeutic Nuclear Medicines Revenue Growth Rate 2014-2019 (Million US$)
    Table Europe Therapeutic Nuclear Medicines Sales by Country (2014-2019) (K Units)
    Table Europe Therapeutic Nuclear Medicines Sales Market Share by Country (2014-2019)
    Figure 2018 Europe Therapeutic Nuclear Medicines Sales Market Share by Country
    Table Europe Therapeutic Nuclear Medicines Revenue by Country (2014-2019) (Million US$)
    Table Europe Therapeutic Nuclear Medicines Revenue Market Share by Country (2014-2019)
    Figure 2018 Europe Therapeutic Nuclear Medicines Revenue Market Share by Country
    Figure Germany Therapeutic Nuclear Medicines Sales Growth Rate (2014-2019) (K Units)
    Figure Germany Therapeutic Nuclear Medicines Revenue Growth Rate (2014-2019) (Million US$)
    Figure France Therapeutic Nuclear Medicines Sales Growth Rate (2014-2019) (K Units)
    Figure France Therapeutic Nuclear Medicines Revenue Growth Rate (2014-2019) (Million US$)
    Figure UK Therapeutic Nuclear Medicines Sales Growth Rate (2014-2019) (K Units)
    Figure UK Therapeutic Nuclear Medicines Revenue Growth Rate (2014-2019) (Million US$)
    Figure Italy Therapeutic Nuclear Medicines Sales Growth Rate (2014-2019) (K Units)
    Figure Italy Therapeutic Nuclear Medicines Revenue Growth Rate (2014-2019) (Million US$)
    Figure Russia Therapeutic Nuclear Medicines Sales Growth Rate (2014-2019) (K Units)
    Figure Russia Therapeutic Nuclear Medicines Revenue Growth Rate (2014-2019) (Million US$)
    Table Europe Therapeutic Nuclear Medicines Sales by Type (2014-2019) (K Units)
    Table Europe Therapeutic Nuclear Medicines Sales Market Share by Type (2014-2019)
    Figure 2018 Europe Therapeutic Nuclear Medicines Market Share by Type
    Table Europe Therapeutic Nuclear Medicines Sales by Application (2014-2019) (K Units)
    Table Europe Therapeutic Nuclear Medicines Sales Market Share by Application (2014-2019)
    Figure 2018 Europe Therapeutic Nuclear Medicines Market Share by Application
    Figure Asia Pacific Therapeutic Nuclear Medicines Sales Growth Rate 2014-2019 (K Units)
    Figure Asia Pacific Therapeutic Nuclear Medicines Revenue Growth Rate 2014-2019 (Million US$)
    Table Asia Pacific Therapeutic Nuclear Medicines Sales by Country (2014-2019) (K Units)
    Table Asia Pacific Therapeutic Nuclear Medicines Sales Market Share by Country (2014-2019)
    Figure 2018 Asia Pacific Therapeutic Nuclear Medicines Sales Market Share by Country
    Table Asia Pacific Therapeutic Nuclear Medicines Revenue by Country (2014-2019) (Million US$)
    Table Asia Pacific Therapeutic Nuclear Medicines Revenue Market Share by Country (2014-2019)
    Figure 2018 Asia Pacific Therapeutic Nuclear Medicines Revenue Market Share by Country
    Figure China Therapeutic Nuclear Medicines Sales Growth Rate (2014-2019) (K Units)
    Figure China Therapeutic Nuclear Medicines Revenue Growth Rate (2014-2019) (Million US$)
    Figure Japan Therapeutic Nuclear Medicines Sales Growth Rate (2014-2019) (K Units)
    Figure Japan Therapeutic Nuclear Medicines Revenue Growth Rate (2014-2019) (Million US$)
    Figure Korea Therapeutic Nuclear Medicines Sales Growth Rate (2014-2019) (K Units)
    Figure Korea Therapeutic Nuclear Medicines Revenue Growth Rate (2014-2019) (Million US$)
    Figure India Therapeutic Nuclear Medicines Sales Growth Rate (2014-2019) (K Units)
    Figure India Therapeutic Nuclear Medicines Revenue Growth Rate (2014-2019) (Million US$)
    Figure Australia Therapeutic Nuclear Medicines Sales Growth Rate (2014-2019) (K Units)
    Figure Australia Therapeutic Nuclear Medicines Revenue Growth Rate (2014-2019) (Million US$)
    Figure Indonesia Therapeutic Nuclear Medicines Sales Growth Rate (2014-2019) (K Units)
    Figure Indonesia Therapeutic Nuclear Medicines Revenue Growth Rate (2014-2019) (Million US$)
    Figure Malaysia Therapeutic Nuclear Medicines Sales Growth Rate (2014-2019) (K Units)
    Figure Malaysia Therapeutic Nuclear Medicines Revenue Growth Rate (2014-2019) (Million US$)
    Figure Philippines Therapeutic Nuclear Medicines Sales Growth Rate (2014-2019) (K Units)
    Figure Philippines Therapeutic Nuclear Medicines Revenue Growth Rate (2014-2019) (Million US$)
    Figure Thailand Therapeutic Nuclear Medicines Sales Growth Rate (2014-2019) (K Units)
    Figure Thailand Therapeutic Nuclear Medicines Revenue Growth Rate (2014-2019) (Million US$)
    Figure Vietnam Therapeutic Nuclear Medicines Sales Growth Rate (2014-2019) (K Units)
    Figure Vietnam Therapeutic Nuclear Medicines Revenue Growth Rate (2014-2019) (Million US$)
    Figure Singapore Therapeutic Nuclear Medicines Sales Growth Rate (2014-2019) (K Units)
    Figure Singapore Therapeutic Nuclear Medicines Revenue Growth Rate (2014-2019) (Million US$)
    Table Asia Pacific Therapeutic Nuclear Medicines Sales by Type (2014-2019) (K Units)
    Table Asia Pacific Therapeutic Nuclear Medicines Sales Market Share by Type (2014-2019)
    Figure 2018 Asia Pacific Therapeutic Nuclear Medicines Market Share by Type
    Table Asia Pacific Therapeutic Nuclear Medicines Sales by Application (2014-2019) (K Units)
    Table Asia Pacific Therapeutic Nuclear Medicines Sales Market Share by Application (2014-2019)
    Figure 2018 Asia Pacific Therapeutic Nuclear Medicines Market Share by Application
    Figure Central & South America Therapeutic Nuclear Medicines Sales Growth Rate 2014-2019 (K Units)
    Figure Central & South America Therapeutic Nuclear Medicines Revenue Growth Rate 2014-2019 (Million US$)
    Table Central & South America Therapeutic Nuclear Medicines Sales by Country (2014-2019) (K Units)
    Table Central & South America Therapeutic Nuclear Medicines Sales Market Share by Country (2014-2019)
    Figure 2018 Central & South America Therapeutic Nuclear Medicines Sales Market Share by Country
    Table Central & South America Therapeutic Nuclear Medicines Revenue by Country (2014-2019) (Million US$)
    Table Central & South America Therapeutic Nuclear Medicines Revenue Market Share by Country (2014-2019)
    Figure 2018 Central & South America Therapeutic Nuclear Medicines Revenue Market Share by Country
    Figure Brazil Therapeutic Nuclear Medicines Sales Growth Rate (2014-2019) (K Units)
    Figure Brazil Therapeutic Nuclear Medicines Revenue Growth Rate (2014-2019) (Million US$)
    Figure Argentina Therapeutic Nuclear Medicines Sales Growth Rate (2014-2019) (K Units)
    Figure Argentina Therapeutic Nuclear Medicines Revenue Growth Rate (2014-2019) (Million US$)
    Table Central & South America Therapeutic Nuclear Medicines Sales by Type (2014-2019) (K Units)
    Table Central & South America Therapeutic Nuclear Medicines Sales Market Share by Type (2014-2019)
    Figure 2018 Central & South America Therapeutic Nuclear Medicines Market Share by Type
    Table Central & South America Therapeutic Nuclear Medicines Sales by Application (2014-2019) (K Units)
    Table Central & South America Therapeutic Nuclear Medicines Sales Market Share by Application (2014-2019)
    Figure 2018 Central & South America Therapeutic Nuclear Medicines Market Share by Application
    Figure Middle East and Africa Therapeutic Nuclear Medicines Sales Growth Rate 2014-2019 (K Units)
    Figure Middle East and Africa Therapeutic Nuclear Medicines Revenue Growth Rate 2014-2019 (Million US$)
    Table Middle East and Africa Therapeutic Nuclear Medicines Sales by Country (2014-2019) (K Units)
    Table Middle East and Africa Therapeutic Nuclear Medicines Sales Market Share by Country (2014-2019)
    Figure 2018 Middle East and Africa Therapeutic Nuclear Medicines Sales Market Share by Country
    Table Middle East and Africa Therapeutic Nuclear Medicines Revenue by Country (2014-2019) (Million US$)
    Table Middle East and Africa Therapeutic Nuclear Medicines Revenue Market Share by Country (2014-2019)
    Figure 2018 Middle East and Africa Therapeutic Nuclear Medicines Revenue Market Share by Country
    Figure GCC Countries Therapeutic Nuclear Medicines Sales Growth Rate (2014-2019) (K Units)
    Figure GCC Countries Therapeutic Nuclear Medicines Revenue Growth Rate (2014-2019) (Million US$)
    Figure Turkey Therapeutic Nuclear Medicines Sales Growth Rate (2014-2019) (K Units)
    Figure Turkey Therapeutic Nuclear Medicines Revenue Growth Rate (2014-2019) (Million US$)
    Figure Egypt Therapeutic Nuclear Medicines Sales Growth Rate (2014-2019) (K Units)
    Figure Egypt Therapeutic Nuclear Medicines Revenue Growth Rate (2014-2019) (Million US$)
    Figure South Africa Therapeutic Nuclear Medicines Sales Growth Rate (2014-2019) (K Units)
    Figure South Africa Therapeutic Nuclear Medicines Revenue Growth Rate (2014-2019) (Million US$)
    Table Middle East and Africa Therapeutic Nuclear Medicines Sales by Type (2014-2019) (K Units)
    Table Middle East and Africa Therapeutic Nuclear Medicines Sales Market Share by Type (2014-2019)
    Figure 2018 Middle East and Africa Therapeutic Nuclear Medicines Market Share by Type
    Table Middle East and Africa Therapeutic Nuclear Medicines Sales by Application (2014-2019) (K Units)
    Table Middle East and Africa Therapeutic Nuclear Medicines Sales Market Share by Application (2014-2019)
    Figure 2018 Middle East and Africa Therapeutic Nuclear Medicines Market Share by Application
    Table Bayer Company Details
    Table Bayer Therapeutic Nuclear Medicines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
    Table Bayer Recent Development
    Table Novartis AG Company Details
    Table Novartis AG Therapeutic Nuclear Medicines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
    Table Novartis AG Recent Development
    Table China Isotope & Radiation Company Details
    Table China Isotope & Radiation Therapeutic Nuclear Medicines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
    Table China Isotope & Radiation Recent Development
    Table Dongcheng Company Details
    Table Dongcheng Therapeutic Nuclear Medicines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
    Table Dongcheng Recent Development
    Table Q BioMed Company Details
    Table Q BioMed Therapeutic Nuclear Medicines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
    Table Q BioMed Recent Development
    Table Curium Pharmaceuticals Company Details
    Table Curium Pharmaceuticals Therapeutic Nuclear Medicines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
    Table Curium Pharmaceuticals Recent Development
    Table Jubilant DraxImage Company Details
    Table Jubilant DraxImage Therapeutic Nuclear Medicines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
    Table Jubilant DraxImage Recent Development
    Table Lantheus Company Details
    Table Lantheus Therapeutic Nuclear Medicines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
    Table Lantheus Recent Development
    Table Spectrum Pharmaceuticals Company Details
    Table Spectrum Pharmaceuticals Therapeutic Nuclear Medicines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
    Table Spectrum Pharmaceuticals Recent Development
    Table Progenics Pharmaceuticals Company Details
    Table Progenics Pharmaceuticals Therapeutic Nuclear Medicines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
    Table Progenics Pharmaceuticals Recent Development
    Table International Isotopes Company Details
    Table Global Therapeutic Nuclear Medicines Sales Forecast by Regions 2019-2025 (K Units)
    Table Global Therapeutic Nuclear Medicines Sales Market Share Forecast by Regions 2019-2025
    Table Global Therapeutic Nuclear Medicines Revenue Forecast by Regions 2019-2025 (Million US$)
    Table Global Therapeutic Nuclear Medicines Revenue Market Share Forecast by Regions 2019-2025
    Table Global Therapeutic Nuclear Medicines Sales Forecast by Type 2019-2025 (K Units)
    Table Global Therapeutic Nuclear Medicines Sales Market Share Forecast by Type 2019-2025
    Table Global Therapeutic Nuclear Medicines Revenue Forecast by Type 2019-2025 (Million US$)
    Table Global Therapeutic Nuclear Medicines Revenue Market Share Forecast by Type 2019-2025
    Table Global Therapeutic Nuclear Medicines Sales Forecast by Application 2019-2025 (K Units)
    Table Global Therapeutic Nuclear Medicines Sales Market Share Forecast by Application 2019-2025
    Figure North America Therapeutic Nuclear Medicines Sales Growth Rate Forecast (2019-2025) (K Units)
    Figure North America Therapeutic Nuclear Medicines Revenue Growth Rate Forecast (2019-2025) (Million US$)
    Figure Europe Therapeutic Nuclear Medicines Sales Growth Rate Forecast (2019-2025) (K Units)
    Figure Europe Therapeutic Nuclear Medicines Revenue Growth Rate Forecast (2019-2025) (Million US$)
    Figure Asia Pacific Therapeutic Nuclear Medicines Sales Growth Rate Forecast (2019-2025) (K Units)
    Figure Asia Pacific Therapeutic Nuclear Medicines Revenue Growth Rate Forecast (2019-2025) (Million US$)
    Figure Central & South America Therapeutic Nuclear Medicines Sales Growth Rate Forecast (2019-2025) (K Units)
    Figure Central & South America Therapeutic Nuclear Medicines Revenue Growth Rate Forecast (2019-2025) (Million US$)
    Figure Middle East and Africa Therapeutic Nuclear Medicines Sales Growth Rate Forecast (2019-2025) (K Units)
    Figure Middle East and Africa Therapeutic Nuclear Medicines Revenue Growth Rate Forecast (2019-2025) (Million US$)
    Table Key Opportunities and Drivers: Impact Analysis (2019-2025)
    Table Key Challenges
    Table Market Risks
    Figure Porter's Five Forces Analysis
    Table Therapeutic Nuclear Medicines Value Chain
    Table Therapeutic Nuclear Medicines Customers List
    Figure Channels of Distribution
    Table Therapeutic Nuclear Medicines Distributors List
    Figure Distributors Profiles
    Table Research Programs/Design for This Report
    Figure Bottom-up and Top-down Approaches for This Report
    Figure Data Triangulation
    Figure Key Executives Interviewed
    Table Key Data Information from Secondary Sources
    Table Key Data Information from Primary Sources
Read More
SELECT A FORMAT
Added to Cart

Single User

Electronic (PDF)
$4900
This license allows only one user(purchaser of the report) to access the PDF.

Multi User

Electronic (PDF)
$7350
This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)
$9800
This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (10% Discount)
OUR CUSTOMER
Strategic Venue Partners

RELATED REPORTS

Clinical Electronic Thermometers Market
Global Clinical Electronic Thermometers Market Research Report 2020

120 Pages
Type: Report
Code: QYRE-Othe-2V432
Thu Mar 25 13:27:19 UTC 2021

Add to Cart

Household Ultrasonic Humidifier Market
Household Ultrasonic Humidifier Market

120 Pages
Type: Report
Code: QYRE-Othe-2Z433
Thu Mar 25 13:37:35 UTC 2021

Add to Cart

Home Nebulizer Market
Global Home Nebulizer Market Insights and Forecast to 2027

120 Pages
Type: Report
Code: QYRE-Othe-2N434
Thu Mar 25 13:50:52 UTC 2021

Add to Cart

0 Items
X
No items in the cart.
$0.0